FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways.

Saved in:
Bibliographic Details
Title: FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways.
Authors: Dixit G; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Gonzalez-Bosquet J; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.; Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Skurski J; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.; Immunology Graduate Program, University of Iowa, Iowa City, Iowa, USA., Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.; Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Dickerson EB; Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.; Animal Cancer Care and Research Program, University of Minnesota, St. Paul, Minnesota, USA., Nothnick WB; Cell Biology and Physiology, Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, Kansas, USA., Issuree PD; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, USA.; Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology, The University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA., Maretzky T; Inflammation Program, University of Iowa, Iowa City, Iowa, USA.; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.; Holden Comprehensive Cancer Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Immunology Graduate Program, University of Iowa, Iowa City, Iowa, USA.
Source: Clinical and translational medicine [Clin Transl Med] 2023 May; Vol. 13 (5), pp. e1223.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2001-1326
DOI:10.1002/ctm2.1223